Tagged with Mexico

Mexico Adium Mexico, recently rebranded to reflect the identity of the broader Adium Group, represents no less than 25 percent of the LatAm group’s sales. General Director José Miguel Fonken Quiroga shares the affiliate’s number one status, stellar growth, vast portfolio, and plans to expand into OTC and vaccines. Fonkel also…

Mexico Johannes Hauser, managing director of the German-Mexican Chamber of Commerce and Industry (AHK Mexico, or CAMEXA locally), shares the chamber’s functions, which include representing the German private sector in Mexico, with a predominance in the pharmaceutical and medical device industries. In addition, he weighs in on the evolution of German…

Mexico Dr Jesus Navarro explains how his personal experience with his daughter’s rare disease led him to form the Mexican Organization for Rare Diseases (OMER) to support others facing similar challenges. Dr Navarro highlights the lack of a comprehensive registry for rare diseases in Mexico and the need for specific legislation…

Mexico The Mexican National Association of Drug Manufacturers (ANAFAM) aims to support its members through advocacy, regulatory support, and professional development. The association’s president, Dr Miguel Lombera, emphasises the importance of ensuring universal healthcare coverage and equal access to primary healthcare and vaccination for all Mexicans; how frequent changes in Mexico’s…

Mexico Dr Germán Fajardo currently serves as Director General of Health Services at leading Mexican university UNAM, having previously been director of its Faculty of Medicine. In conversation Dr Fajardo emphasises the vital importance of providing medical students with a holistic education that includes technical, scientific, and human aspects; highlights some…

Mexico Gisela Ayala outlines the Mexican Diabetes Federation’s focus on educating people with diabetes, healthcare providers, and the general public to dispel myths and improve diabetes management. She highlights the significant progress in diabetes management technology as well as the challenges of ensuring equitable access to these innovations, and her priorities…

Mexico Present in Mexico for over 50 years, the medical device firm Medtronic boasts a large manufacturing footprint in the country. VP for North and Latin America and president of the National Trade Association for Medical Technology Innovations (AMID) Hector Orellana discusses the spectacular growth of Mexico’s manufacturing sector; the legislative…

Mexico Joao Carapeto outlines Roche Diagnostics’ commitment to innovation, prevention, and diagnostics, emphasizing the need for robust partnerships and increased investment in early detection to address Mexico’s healthcare challenges. He highlights the significance of managing an aging population and improving the quality of life through advanced healthcare solutions.   Prevention and…

Mexico FUNSALUD is a leading Mexican think tank focused on improving public health through research, advocacy, and promoting public-private partnerships. As Mexico prepares to welcome a new president, FUNSALUD’s Hector Valle casts his eye over the evolving healthcare landscape in terms of both progress made in addressing access gaps and how…

Mexico This year has seen no less than five GM changes at international pharma companies’ Mexican affiliates. Pfizer, MSD, Roche, Sanofi and Gilead have all taken on new local leadership. In some cases, the appointments represent a first for affiliates that have never had female leaders while in others they coincide…

Mexico Drawing on an industry track record of over 25 years, Fernando Fogarin has recently become the strategic project lead for emerging markets at women’s health specialist Organon. He shares his priorities and the particularities of the Mexican market, discussing the positive impact of the country’s upcoming biosimilars reform; Organon’s efforts…

Mexico Mexico’s president-elect Claudia Sheinbaum recently revealed some of her key cabinet choices, naming eminent physician and researcher David Kershenobich as the country’s new health secretary. When Kershenobich takes office in October he will be inheriting a healthcare system rife with medicine shortages, partially adopted systems and inadequate resources. However, rather…